- Finance Megaphone
- Posts
- Trump on Big Pharma
Trump on Big Pharma
The Smart Budget Blueprint

Welcome to Finance Megaphone – Your Free Source for Financial News
At Finance Megaphone, we bring you the latest and most relevant updates from the world of finance. Whether it's market trends, breaking news, or insights from industry experts, we’ve got you covered. Stay informed, stay ahead, and make smarter financial decisions with the news that matters most.
Let’s dive into what’s happening in the market today!
The DeFi Mullet: Why the Future of Fintech Has DeFi in the Back
Trump Turns Up the Heat on Big Pharma: Drug Prices, Tariffs, and Onshoring in Focus
The Smart Budget Blueprint: Must-Have Categories for Financial Success
The DeFi Mullet: Why the Future of Fintech Has DeFi in the Back
Fintechs are sleek on the surface but still rely on outdated, costly traditional infrastructure. Enter the DeFi mullet—fintech in the front, decentralized finance (DeFi) in the back. By merging DeFi’s fast, low-cost, always-on infrastructure with fintech’s polished user experience, companies can unlock scalable, transparent, and innovative financial services. From instant stablecoin transfers to onchain lending, DeFi empowers fintechs with control, flexibility, and access to global liquidity—without disrupting user familiarity. As regulation evolves and major institutions move onchain, integrating DeFi isn’t just a tech upgrade—it’s a strategic necessity. The future of finance is hybrid, and the mullet is here to stay.
Trump Turns Up the Heat on Big Pharma: Drug Prices, Tariffs, and Onshoring in Focus
The Trump administration is intensifying its push to lower drug prices and bring pharmaceutical manufacturing back to the U.S. without directly setting price caps. Special adviser Calley Means emphasized aligning U.S. drug prices with those in Europe and condemned pharma giants like Roche for threatening to withdraw investment. A new executive order, the "Most Favored Nation" policy, aims to ensure Americans pay no more than other wealthy nations for medications. Amid rising tariffs and industry pressure, companies like Johnson & Johnson, Eli Lilly, and AstraZeneca have pledged billions to onshore operations, but tensions are mounting as Trump refuses to back down.
Finance Megaphone for Finance bUzz
Tackle your credit card debt by paying 0% interest until nearly 2027
If you have outstanding credit card debt, getting a new 0% intro APR credit card could help ease the pressure while you pay down your balances. Our credit card experts identified top credit cards that are perfect for anyone looking to pay down debt and not add to it! Click through to see what all the hype is about.
The Smart Budget Blueprint: Must-Have Categories for Financial Success
Want to take control of your money? Build a budget that works by dividing your spending into three core categories: needs, wants, and savings following the popular 50/30/20 rule. Needs include essentials like housing, food, transportation, and healthcare; wants cover fun expenses like dining out, streaming, and hobbies; and savings go toward goals like retirement, emergency funds, and debt payoff. Use this detailed category list to track your spending, set realistic goals, and adjust as needed to fit your lifestyle. A budget isn’t one-size-fits-all customize it to create financial stability that lasts.
some our tweets
Whats happen in finance today
Trump doubles down on cutting drug prices and onshoring pharma.
Fintechs are merging sleek user experiences with powerful DeFi backends.
Want control of your finances?Master the 50/30/20 rule and budget by needs, wants, and savings.
— Finance Megaphone (@Financemeg_news)
9:15 PM • May 17, 2025
That’s a wrap for this edition of Finance Megaphone.
We hope the insights and updates we’ve shared help you stay informed and ready to take on the market. Remember, knowledge is power, and we’re here to keep you in the know every step of the way. Be sure to check back next edition for more timely news, expert analysis, and the latest trends in the financial world.
Until then, keep investing smart and stay ahead of the curve!